Search Results - "Majidpoor, Jamal"

Refine Results
  1. 1

    Steps in metastasis: an updated review by Majidpoor, Jamal, Mortezaee, Keywan

    “…Metastasis is the most complex and deadly event. Tumor-stromal interface is a place where invasion of tumor cells in the form of single-cell or collective…”
    Get full text
    Journal Article
  2. 2

    Angiogenesis as a hallmark of solid tumors - clinical perspectives by Majidpoor, Jamal, Mortezaee, Keywan

    Published in Cellular oncology (Dordrecht) (01-08-2021)
    “…Background Angiogenesis is a key and early step in tumorigenesis, and is known as a hallmark of solid tumors and a key promoter of tumor recurrence. Unlike…”
    Get full text
    Journal Article
  3. 3

    Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications by Majidpoor, Jamal, Mortezaee, Keywan

    Published in Biomedicine & pharmacotherapy (01-01-2022)
    “…Interleukin-6 (IL-6) is a multi-tasking cytokine that represents high activity in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
    Get full text
    Journal Article
  4. 4

    Key promoters of tumor hallmarks by Mortezaee, Keywan, Majidpoor, Jamal

    “…Evolution of tumor hallmarks is a result of accommodation of tumor cells with their nearby milieu called tumor microenvironment (TME). Accommodation or…”
    Get full text
    Journal Article
  5. 5

    Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1 by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Biomedicine & pharmacotherapy (01-07-2023)
    “…CD8+ T cells are the front-line defensive cells against cancer. Reduced infiltration and effector function of CD8+ T cells occurs in cancer and is contributed…”
    Get full text
    Journal Article
  6. 6

    The current knowledge concerning solid cancer and therapy by Najafi, Masoud, Majidpoor, Jamal, Toolee, Heidar, Mortezaee, Keywan

    “…Solid cancers comprise a large number of new cases and deaths from cancer each year globally. There are a number of strategies for addressing tumors raised…”
    Get full text
    Journal Article
  7. 7

    Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Cellular oncology (Dordrecht) (01-06-2022)
    “…Macrophages are the most abundant and one of the most critical cells of tumor immunity. They provide a bridge between innate and adaptive immunity through…”
    Get full text
    Journal Article
  8. 8

    Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy by Rouzbahani, Elnaz, Majidpoor, Jamal, Najafi, Sajad, Mortezaee, Keywan

    Published in Biomedicine & pharmacotherapy (01-12-2022)
    “…Tumor microenvironment (TME) takes critical roles in tumor resistance to immune checkpoint inhibitors (ICIs) including anti-programmed death-1 (PD-1) or…”
    Get full text
    Journal Article
  9. 9

    (Im)maturity in Tumor Ecosystem by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Frontiers in oncology (25-01-2022)
    “…Tumors have special features that make them distinct from their normal counterparts. Immature cells in a tumor mass and their critical contributions to the…”
    Get full text
    Journal Article
  10. 10

    CD8 + T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Frontiers in immunology (01-04-2022)
    “…Dysregulated innate and adaptive immunity is a sign of SARS-CoV-2-induced disease and cancer. CD8 T cells are important cells of the immune system. The cells…”
    Get full text
    Journal Article
  11. 11

    Reinstating immunogenicity using bispecific anti-checkpoint/agent inhibitors by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Biomedicine & pharmacotherapy (01-06-2023)
    “…Immune checkpoint inhibitor (ICI) resistance demands for acquisition of novel strategies in order to broaden the therapeutic repertoire of advanced cancers…”
    Get full text
    Journal Article
  12. 12

    Macrophage polarity in cancer: A review by Najafi, Masoud, Hashemi Goradel, Nasser, Farhood, Bagher, Salehi, Eniseh, Nashtaei, Maryam Shabani, Khanlarkhani, Neda, Khezri, Zahra, Majidpoor, Jamal, Abouzaripour, Morteza, Habibi, Mohsen, Kashani, Iraj Ragerdi, Mortezaee, Keywan

    Published in Journal of cellular biochemistry (01-03-2019)
    “…Macrophages are the most abundant cells within the tumor stroma displaying noticeable plasticity, which allows them to perform several functions within the…”
    Get full text
    Journal Article
  13. 13

    Checkpoint inhibitor/interleukin‐based combination therapy of cancer by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Cancer medicine (Malden, MA) (01-08-2022)
    “…Background Immunotherapy using immune checkpoint inhibitors (ICIs) is the current focus in cancer immunotherapy. However, issues are raised in the area, as the…”
    Get full text
    Journal Article
  14. 14

    Bypassing anti-PD-(L)1 therapy: Mechanisms and management strategies by Mortezaee, Keywan, Majidpoor, Jamal, Najafi, Sajad, Tasa, Davood

    Published in Biomedicine & pharmacotherapy (01-02-2023)
    “…Resistance to immune checkpoint inhibitors (ICIs) is a major issue of the current era in cancer immunotherapy. Immune evasion is a multi-factorial event, which…”
    Get full text
    Journal Article
  15. 15

    Cellular immune states in SARS-CoV-2-induced disease by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Frontiers in immunology (23-11-2022)
    “…The general immune state plays important roles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Cells of the immune system are…”
    Get full text
    Journal Article
  16. 16

    The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapy by Mortezaee, Keywan, Majidpoor, Jamal, Kharazinejad, Ebrahim

    Published in Biomedicine & pharmacotherapy (01-06-2023)
    “…Extending the durability of response is the current focus in cancer immunotherapy with immune checkpoint inhibitors (ICIs). However, factors like…”
    Get full text
    Journal Article
  17. 17

    An update on the role of miR-124 in the pathogenesis of human disorders by Ghafouri-Fard, Soudeh, Shoorei, Hamed, Bahroudi, Zahra, Abak, Atefe, Majidpoor, Jamal, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-03-2021)
    “…[Display omitted] MicroRNA-124 (miR-124) is a copious miRNA in the brain, but it is expressed in a wide range of human/animal tissues participating in the…”
    Get full text
    Journal Article
  18. 18

    Regulatory role of microRNAs on PTEN signaling by Ghafouri-Fard, Soudeh, Abak, Atefe, Shoorei, Hamed, Mohaqiq, Mahdi, Majidpoor, Jamal, Sayad, Arezou, Taheri, Mohammad

    Published in Biomedicine & pharmacotherapy (01-01-2021)
    “…Phosphatase and tensin homolog (PTEN) gene encodes a tumor suppressor protein which is altered in several malignancies. This protein is a negative regulator of…”
    Get full text
    Journal Article
  19. 19

    The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade by Najafi, Sajad, Majidpoor, Jamal, Mortezaee, Keywan

    Published in Biomedicine & pharmacotherapy (01-05-2023)
    “…Immunotherapy has revolutionized treatment of cancer during the last decades. Oncolytic virotherapy has also emerged as a strategy to fight against cancer…”
    Get full text
    Journal Article
  20. 20

    Alternative immune checkpoints in immunoregulatory profile of cancer stem cells by Mortezaee, Keywan, Majidpoor, Jamal

    Published in Heliyon (01-12-2023)
    “…Tumor-mediated bypass of immune checkpoint inhibitor (ICI) therapy with anti-programmed death-1 (PD-1), anti-programmed death-ligand 1 (PD-L1, also called…”
    Get full text
    Journal Article